Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BEZAFIBRATE for Primary biliary cholangitis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 13 adverse event reports in the FDA FAERS database where BEZAFIBRATE was used for Primary biliary cholangitis.

Most Reported Side Effects for BEZAFIBRATE

Side Effect Reports % Deaths Hosp.
Myalgia 29 9.5% 0 6
Abdominal pain 25 8.2% 0 10
Rhabdomyolysis 21 6.9% 0 17
Back pain 20 6.6% 0 4
Blood creatine phosphokinase increased 19 6.2% 0 5
Acute myocardial infarction 17 5.6% 0 3
Pancreatitis acute 17 5.6% 0 17
Pyrexia 16 5.3% 0 2
Acute coronary syndrome 15 4.9% 0 1
Drug intolerance 15 4.9% 0 0
Hypertension 15 4.9% 0 1
Off label use 15 4.9% 1 2
Pulmonary embolism 15 4.9% 1 15
Arthralgia 14 4.6% 1 2
Carotid arteriosclerosis 14 4.6% 0 0

Other Indications for BEZAFIBRATE

Product used for unknown indication (97) Dyslipidaemia (44) Hyperlipidaemia (35) Hypercholesterolaemia (26) Blood cholesterol increased (13) Blood cholesterol (7) Cholangitis (6) Cholangitis sclerosing (6) Type iia hyperlipidaemia (6)

Other Drugs Used for Primary biliary cholangitis

OBETICHOLIC ACID (4,838) ELAFIBRANOR (288) URSODIOL (203) FENOFIBRATE (40) SELADELPAR LYSINE (39) SELADELPAR (36) AZATHIOPRINE (14) PREDNISONE (11) RITUXIMAB (11) BUDESONIDE (8)

Related Pages

BEZAFIBRATE Full Profile All Primary biliary cholangitis Drugs BEZAFIBRATE Demographics BEZAFIBRATE Timeline